New US ambulatory electrocardiograph standard:
This article was originally published in Clinica
Executive Summary
The Association for the Advancement of Medical Instrumentation (AAMI) in the US has released a revision of the Ambulatory Electrocardiographs American National Standard which focuses on minimum requirements for safety and effectiveness of ECG equipment. Approved by the American National Standards Institute, the revised ANSI/AAMI EC38 standard covers how to effectively obtain a cardiac rhythm signal from the surface of a patient's body and transmit the signal to a recording device. Updates to the document include changes to the sections pertaining to stationary equipment, defibrillator energy shunting and an expanded section on electromagnetic compatibility. It will be especially useful to device purchasers, says AAMI, because it provides a precise description of the characteristics and limitations of ambulatory ECG equipment.
You may also be interested in...
COVID-19 Vaccines Donated To Philippines Require Emergency Use Authorization
Days after a senior Chinese government official offered free COVID-19 vaccines to the Philippines government, the country’s medicines regulator said the donated jabs would need an emergency approval before they can be used on the public.
Purespring Therapeutics: Pioneering Gene Therapy For Kidney Disorders
Interview: recently appointed CEO Richard Francis will apply his background in big pharma and biotech to building the UK start-up Purespring Therapeutics with a focus on using gene therapy technology to target renal diseases.
Sandoz Pioneers Posaconazole And Silodosin In Canada
Sandoz Canada has become the first manufacturer to launch generic versions of posaconazole and silodosin in Canada. The company launched the generic version of Allergan’s Rapaflo (silodosin) after a Canadian court ruled that Sandoz did not infringe a key formulation patent.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: